• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[大量输血相关的凝血问题。一项实验研究(作者译)]

[Coagulation problems associated with massive blood transfusions. An experimental study (author's transl)].

作者信息

Witzke G, Abdulla W

出版信息

Anaesthesist. 1979 Jul;28(7):322-7.

PMID:484820
Abstract

During storage banked blood show changes as far as function and concentration of their corpuscular and plasmatic ingredients are concerned. Antihaemophilic globulin (factor VIII) and pro-accelerin (factor V) in particular lose their activities so quickly that only very few activities still remain after a storage period of 3-5 days. In connection with existing primary diseases but also in trauma and shock a dilution-coagulopathy caused by insufficient supply of factors VIII and V can develop during massive transfusion, and this especially with banked blood already stored over a longer period of time. Therapy of this disturbance of coagulation consists of substituting the missing coagulation factors under heparin protection.

摘要

在储存期间,库存血在其细胞成分和血浆成分的功能及浓度方面会发生变化。特别是抗血友病球蛋白(因子VIII)和前加速素(因子V)会迅速失去活性,以至于在储存3至5天后仅剩下极少的活性。在存在原发性疾病的情况下,以及在创伤和休克时,大量输血过程中可能会因因子VIII和V供应不足而引发稀释性凝血病,尤其是使用已经储存较长时间的库存血时。这种凝血障碍的治疗方法是在肝素保护下补充缺失的凝血因子。

相似文献

1
[Coagulation problems associated with massive blood transfusions. An experimental study (author's transl)].[大量输血相关的凝血问题。一项实验研究(作者译)]
Anaesthesist. 1979 Jul;28(7):322-7.
2
Coagulation disorders in massively injured patients.
Prog Clin Biol Res. 1982;108:213-24.
3
Coagulation findings in rats with experimental hypersplenism and their changes after splenectomy and after administration of adrenaline.实验性脾功能亢进大鼠的凝血指标及其在脾切除术后和给予肾上腺素后的变化
Thromb Diath Haemorrh. 1970 Jun 30;23(3):593-600.
4
[Recommendations for transfusion therapy. Volume substitution, raising oxygen transport capacity and replacement of clotting factors (author's transl)].输血治疗建议。容量替代、提高氧运输能力及凝血因子替代(作者译)
MMW Munch Med Wochenschr. 1979 Aug 10;121(32-33):1051-4.
5
Coagulation disorders in severely and critically injured patients.严重和危重伤员的凝血障碍
Ann Chir Gynaecol. 1977;66(6):269-77.
6
Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days.凝血因子在解冻的、经溶剂/去污剂处理的血浆中于4℃储存6天期间的稳定性。
Vox Sang. 2004 Oct;87(3):182-6. doi: 10.1111/j.1423-0410.2004.00552.x.
7
Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1-6 degrees C for five days.在1至6摄氏度下对单采解冻新鲜冰冻血浆中的凝血因子活性进行为期五天的研究。
J Clin Apher. 2006 Dec;21(4):224-6. doi: 10.1002/jca.20095.
8
[Concentrated antihemophilic globulin in the treatment of hemorrhagic syndromes].[浓缩抗血友病球蛋白在出血综合征治疗中的应用]
Bilt Hematol Transfuz. 1976;4(3):61-6.
9
[Diagnostics and therapy of hemolytic-hemorrhagic transfusion incidents].
Zentralbl Neurochir. 1972;33(1):63-8.
10
[Hemostasis disorders after transfusions].输血后的止血障碍
Folia Haematol Int Mag Klin Morphol Blutforsch. 1981;108(3):345-66.